A convenient and quantifiable model system, Semliki Forest virus (SFV) in the mouse, has been used to probe the wider problem of the radiation sensitivity of the distinct phases of the virus-host interaction. This has been investigated through the suppression and recovery of the several host defence mechanisms and cellular compartments involved. Direct observations have been made, following whole-body y-irradiation at up to 60o R, of the sequential modifications imposed upon the efficiency of primary infection, the stimulation of regulatory immunity (pre-challenge) and the stimulation or boosting of protective immunity (postchallenge). These phases of the virus-host interaction show distinct sensitivities to y-radiation which are discussed in terms of the impairment and recovery of the lymphocyte compartments probably involved.
INTRODUCTION
Studies on the strict in vivo specification of virus strains and on the course of their interactions with the host are aided by comparative observations on the responses to infection of immature (Walder & Bradish, I975, I979; Fitzgeorge & Bradish, I98o) or immunomodified hosts (Nathanson & Cole, I971; Bradish et al. 1975a, b) in which particular classes of responsive cells may be lacking or impaired.
In many of these cases considerable practical difficulties arise in the identification of the impaired cellular subclasses (Anderson & Warner, ~976; Katz, ~977) and in the assessment of their in vivo functional levels in relation to drug-dose regimen and the differential recoveries from impairment. These effects are of particular concern during the rapid replication, stimulation and regulation which follow virus infection and programme the immunological future of the host.
The present study considers the extent to which whole-body exposure of the mouse to graded doses of y-radiation may provide a test-host in which the regulation of the distinct phases of the virus-host interaction may be resolved more sensitively. This contributes to the general problem of the stimulation of host defences against virus infection and of the critical balances in immune stimulation between immunogenicity (of virus) and immunocompetence (of host).
Strains of virus.
The strains of Semliki Forest virus (SFV) used in this study have been defined by Bradish et al. (I97I, t97z) , Bradish & Allner (I972) and Bradish et al. 0979) . These citations also give details of the assay procedures involved. Primary intraperitoneal (i.p.) infections by single or graded doses of the clonally selected avirulent strain (A774. C3) of SFV were followed 7 to z~ days later by lethal challenge with io 4 p.f.u.i.p, of the defined virulent strain (LIo.Ci) of SFV.
Procedures in mice. Mice of various strains were used as quoted at 3o to 7o days old in groups of about I o. At stated times after primary infection (A774. C3) or virulent challenge (L~o. C I) mice were killed for survey of tissue infectivities, or were bled individually from the retro-orbital plexus. Blood samples were mixed with an equal volume of heparin BP in saline (lo units/ml) and the plasma samples derived were held at -2o °C until assayed for infectivity, interferon activity or neutralizing antibody activity (Fitzgeorge & Bradish, I973) . As detailed in the above citations, all of these assay procedures were based upon the estimation of virus infectivity by plaque counting in agar suspensions of primary chick embryo cells (infectivity, antibody activity) or mouse L-cells (interferon activity).
Exposure of mice to y-radiation. Normal mice to be y-irradiated were confined in troughs made of I mm aluminium sheet (55 mm deep x 50 mm wide x 285 mm long). Five mice were confined in each trough and two troughs were placed one above the other in a standard plastic mouse box 03o mm deep x I3O mm wide x 325 mm long) which was exposed at a distance of 8o0 mm from a Co 6° source of 4ooo Ci.
The y-dose rate within the mouse boxes (28oo to 3200 R/h) was confirmed in each test by FeSO, dosimetry (Attix et al. 1966) . After exposure to y-radiation for up to I2 rain (6oo R) the mice were housed in groups of five under the barrier conditions used for athymic-nude mice (Bradish et al. I979) .
Observations of distinct phases of host response to virus infection
Groups of y-irradiated or normal control mice infected i.p. by single or graded doses of the avirulent strain (A774. C3) of SFV were subsequently observed for the following distinct phases of the virus-host interaction (Walder & Bradish, I975, 1979; Bradish et al. 1979) .
Efficiency ofprhnary infection. This is assessed through any indicator of positive infection and replication (clinical signs, viraernia, interferon synthesis, antibody synthesis) and is quantified as efficiency of infection by the ratio of IDs0 units for the test-host to p.f.u administered. When serially graded doses of virus were used, the interpolation procedure of Reed & Muench (1938) was adopted for the estimation of the infective particle (p.f.u.) input required for I IDs0 in the test-host.
Regulatory inm~unity and the expression of virulence. This is indicated by the severity, rate of development and duration of clinical signs and tissue infectivities following positive infection. For tests on mice with the A774. C3 strain of SFV this involves either death within 7 to 14 days of infection or a benign infection indicated only by the consequences of virus replication and immunogenicity, such as the time course of positive viraemia and interferon or antibody synthesis.
Protective immunity. This is distinct from the regulatory immunity above and is assessed only through the host responses and boosting stimulations that follow a secondary challenge infection by the virulent L J o. Ct strain of SFV. In the present tests, the quality of protective stimulation is indicated by the incidence or duration of survival following the lethalchallenge infection and by the extent of any parallel enhancement of serum antibody activity. Interferon activity, log (units/ml blood) 
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RESULTS
Efficiency of infection
In representative experiments, groups of inbred Balb/C and Ht6 mice were exposed to up to 45o R of y-radiation and then inoculated i.p. I day later with 3o or 3o0o p.f.u, of the A774. C3 strain of SFV. Two days later mice were bled individually for assay of viraemia and interferon activity: these are the earliest and least virus strain-related indicators of positive infection (Bradish & Allner, ~97z) . A further bleeding was made 13 days later for assay of serum antibody activity. The results in Fig. I show no significant variation of incidence or efficiency of infection with whole-body y-doses up to 45o R. At 3o p.f.u, and regardless of y-dose, seven of 35 mice were uninfected (z/17 Balb/C, 5/~8 Ht6) on the basis of no detectable viraemia or interferon activity at 2 days or antibody activity at I3 days. This indicates that 9'7 (Balb/C) or I6-2 (Ht6) p.f.u, were required for the IDs,, at any y-dose and corresponds with a radiation-stable efficiency of infection of about o'o8.
Furthermore, the evidently vigorous replication of virus following infection by 30 p.f.u. or 3ooo p.f.u., and the constant relationship between viraemia and interferon activity at all y-doses, indicate that primary sites of infection and earliest patterns of replication in muscle and peritoneal wall (Pusztai et al. ]97I ; Smillie et al. 1973) are similarly involved in the normal and y-irradiated mouse.
In similar control experiments mice of various strains were exposed to up to 5oo R of whole-body y-radiation and then used for the conventional titration of virus infectivity by the inoculation of serially graded doses of virus. These tests again showed that the efficiency 
Regulation of viraemia and antibody synthesis
Just as the initial rises of viraemia and interferon activity within z days of infection are indicators of primary infection and virus replication, so the subsequent changes of viraemia and antibody activity are consequences of the immune stimulations and regulations associated with the increasing immunogenic mass of virus (Bradish et al. I975b) .
The results in Fig. z (a, b) for individual ranges of viraemia and antibody activity show a wide spread but a clear distinction between the responses of unirradiated mice and those of mice exposed to 25o or 350 R of y-radiation. The development of viraemia is checked by the second day of infection in all irradiated and control mice and the clearance of viraemia is delayed by about 2. 5 or 6 days in mice previously exposed to 25o or 35o R; this is shown further in Fig. 3 -
The impaired regulation and decline of viraemia is related inversely to a much more complete suppression of antibody synthesis for the first 7 days (Fig. 2b) . Thus viraemia may be regulated by an early activity of informed cells or circulating antibody which is effective within 2 to 3 days of infection at a level which is significantly below the threshold sensitivity of the present assays for humoral stimulation.
It is significant that of ten mice exposed to 25 ° R and bled at 7 days, the three of highest viraemia 0089, IO 26, lo g.° p.f.u./ml) still showed no detectable serum neutralizing activity. 
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Thus all mice at 7 days p.i. (8 days post-radiation) were either positive in viraemia and negative in antibody conversion, or vice versa.
When these mice were lethally challenged at 7 days after primary infection, none died in the y-irradiated or control groups. After bleeding at [6 days following lethal challenge, the serum neutralization indices were as indicated at day 23 in Fig. 2(b) . Thus, despite the dramatic suppression of primary antibody synthesis by exposure to 250 or 35o R, all mice were nevertheless protected against this early lethal challenge and capable of responding to its immunogenic stimulation. This secondary stimulation gave modal antibody activities I6 days later which were 6% (35o R) and I70;, (z5o R) of that for the group of unirradiated mice. Thus primary stimulation had occurred even in the 35 ° R exposed mice for which no primary antibody conversion was detected.
Influence of y-dose upon viraemia and antibody synthesis
In further tests on the early recovery of mice from exposure to a range of doses of yradiation up to 45o R, groups of mice were infected with 3ooo p.f.u, of SFV strain A774. C3 at [ day after y-exposure. The results in Fig. 3 show that the development of viraemia at up to 2 days p.i. was little influenced by y-exposure. However, by 5 to 6 days p.i. only mice receiving less than about z5o R of y-radiation showed the normal complete elimination of viraemia. Mice receiving from 15o to 45o R showed progressive delays in regulation and clearance of viraemia, although even at 45o R all mice were non-viraemic within about Iz days.
The parallel assays of serum antibody activity (Fig. 3 b) showed a progressive depression or delay of antibody stimulation. Thus, normal mice at 6 days p.i. showed levels of neutralizing activity which were not attained until 13 to 14 days in mice exposed to 35o R. However, c.J. BRADISH, D. TITMUSS AND R. FITZGEORGE even exposure to 45o R of y-radiation only delayed the emergence of serum neutralizing activity.
It must be noted that in mice exposed to 350 to 450 R a total clearance of viraemia was established within I3 days despite a still greatly depressed (< 2 %>) stimulation of neutralizing antibody activity. Thus, as in the previous section, the detected levels and timings of serum antibody activity do not indicate directly the mechanisms regulating levels of viraemia in y-exposed mice.
Influence of dose of virus upon immunogenicity and sensitivity of response to y-exposure
To test the influence of dose of virus upon the stimulation of regulatory immunity (prechallenge) and protective immunity (post-challenge) in the y-exposed mouse, groups of ten A2G mice at 3o to 35 days old were infected i.p. by 30, 3oo or 3ooo p.f.u, of SFV strain A774. C3 at I day following whole-body exposure to o, 150,250, 350 or 45o R of y-radiation. Other test conditions are generally as in previous sections and in Methods.
The results are shown in Fig. 4 as the distributions of responses for individual mice. This emphasizes the individuality of the virus-host interaction and the inverse relationship between the dose of infecting virus and the sensitivity to y-exposure of responses to virus stimulation. These details of host response cannot be expressed by group averages.
Four patterns of antibody suppression were observed in terms of levels of neutralizing activity at 6 and I4 days following primary infection. Some mice (6/30) infected by only 3o p.f.u, after y-exposure at r5o to 2oo R showed no detectable neutralizing antibody activity (< ~'5 SNI) at 6 or 14 days. This pattern was also shown by 8/19 mice infected by 28o to 27oo p.f.u, but only after the highest y-exposure at 450 R; these mice without detectable antibody conversion are shown heavily shaded in Fig. 4 . Some less y-sensitive mice showed no antibody conversion at 6 days and a positive but impaired conversion at 14 days. Such impairments or delays of antibody synthesis occurred only above y-doses of 35 o R for an infecting dose of 2700 p.f.u, but at y-doses as low as 15o to 2oo R for the lowest virus dose of 30 p.f.u. All remaining mice to the left of the diagonal line in Fig. 4 showed normal antibody conversion at 6 and 14 days, apart from 5 of 18 normal mice infected by 2700 p.f.u. which failed to sustain antibody synthesis to 14 days.
Significant changes in the distribution and persistence of viraemia at 6 days following infection occurred at higher y-doses (diagonal line in Fig. 4 ) than those initiating changes in antibody synthesis. Viraemia in mice infected by only 3o p.f.u, was highly sensitive to y-exposure at I5o to 250 R which had minimal effect on viraemia in mice infected by 28o to 2700 p.f.u.
When these mice were lethally challenged at 2I days after primary infection, all survived as 'protected' and without clinical signs except those indicated by black spots in Fig. 4 . Such mice, dying through failure of protective immunity, showed no systematic association with high or low viraemia, or with the pattern of impaired antibody synthesis. Failures of protective immunity occurred at y-doses as low as t5o R for primary infective doses of 3o p.f.u., but only at 35o to 450 R for higher infecting doses of 280 to 2700 p.f.u.
These results show that although the impairments of the regulation of viraemia and antibody synthesis, and the development of protective immunity, cannot be correlated directly, all are related progressively to y-dose and inversely to stimulating virus dose. This suggests either that higher doses of virus can better stimulate less avid and more y-resistant subsets of cells, or that events following infection and stimulation can accelerate the recovery from y-insult of immunocompetent cells. 
Regulation and decline of infectivity in brain
As in previous sections concerning the regulation and clearance of viraemia, the regulation and clearance of brain infectivity is an important indicator of the immunological responses that regulate the expression of virulence (Bradish & Allner, 1972; Bradish et al. 1979) .
Groups of control Balb/C mice and those exposed to 500 R of y-'radiation were infected i.p. I day later with 3o00 p.f.u, of the avirulent strain of SFV. At various times later, and particularly at the time of severe clinical signs (5 to 7 days) preceding death (6 to I3 days), mice were killed to provide samples of brain and blood for assay of infectivity and neutralizing activity. Brain infectivities were r, educed to undetectable levels in normal mice within about 9 days of infection and only one of nine control mice died. By contrast, mice preexposed to 5oo R of y-radiation showed elevation of brain infectivity by at least loo-fold and an equivalent delay of about 4 days in the course of the subsequent clearance of brain infectivity. Thus the y-exposed mice showed elevated brain infectivities of from lO 6 to IO 8 p.f.u./brain from about the 5th to the Ioth days of infection: this is consistent with the high incidence of deaths (8/Io) I to 3 days later. This regulation and decline of brain infectivity in y-exposed mice at 6 to 12 days follows very closely that already described for nude-athymic mice. However, y-exposed mice clear brain infectivity completely within about 17 days whereas athymic-nude mice then maintain a fluctuating persistence of up to Io ~ p.f.u./brain for at least 7 weeks (Bradish et al. 1979) .
Depression of regulatory and protective immunity by y-irradiation
Following positive infection by virus and the generation by replication of a range of immunogens, the normally responding host may show that an effective regulatory immunity has been stimulated. If the host also survives a later lethal challenge then an effective protective immunity has also been established following primary and secondary stimulations.
The results in Fig. 5 for several strains of mice show that the normally efficient regulatory immunity, indicated by the survival of the host following primary infection, may be little influenced by 7-doses up to 300 R. Beyond this however, the incidence of primary deaths (D in Fig. 5 ) may increase sharply at 45o R and above; this is not associated with any deaths due to y-radiation alone.
In contrast to this relative ?'-stability of regulatory imnmnity and expression of virulence in mice exposed to up to 4oo R, the incidence of protective immunity may decline significantly at doses below 4o0 R (Fig. 5a ). This appears to be particularly so for the strains C3 H and C57 but less so for the strains Balb/C and Ht6. The mortality following virulent challenge is significantly greater in the 3oo R exposed mice than in the normal mice, but then declines for the 45o R exposed mice (strains C57, C3H, Ht6) as many more now die after primary infection (D in Fig. 5 ). Thus failure of protective immunity (S) shifts to failure of regulatory immunity (D) as y-doses increase from 3oo to 45o R, or to 5oo R for A2G mice (results not shown in Fig. 5 )-
Recovery from radiation exposure
To test the rates of recovery of the several components of immunity after whole-body exposure, groups of normal AzG mice were exposed to 460,580 or 7oo R. Direct radiation lethalities were 24"/~, (19/78) . Groups of t6 to 50 mice of different strains at 30 to 50 days old were infected i.p. by 30o0 p.f.u, of avirulent SFV (A774. C3) at 24 h following whole-body irradiation at 3oo R or 450 R. Mice were then observed for the incidence of death within t4 days or of susceptibility to lethal challenge at r 4 to 21 days. The figure shows the increased incidence of death (D) or susceptibility to lethal challenge (S) in y-exposed mice compared with that in control, unirradiated mice. Significance levels are shown by broken lines. uniformity in rate of recovery of about 12 days per mo R of y-exposure. The most important change, as shown also by the several previous results, occurs in the threshold y-radiation doses at which particular impairments of host-response may be observed. In these terms the impairment of antibody synthesis and the delay of viraemia clearance (change from P+ to P-in Fig. 6 ) have a 5o °//o response threshold of about I5O to 2oo R in mice infected within I day of exposure. The corresponding 5o % response threshold for the impairment of protective immunity against challenge is about 25o to 3oo R (change from P-to S in Fig. 6 ). The impairment of regulatory immunity and the change of response from benign to lethal infection (S to D in Fig. 6 ) occurs at a threshold of 45 o R or higher according to the strain of mice (Fig. 5) . Fig. 6 is of particular interest as a response phase diagram showing the zones, or conditions of y-radiation dose and recovery time, for which the majority of infected mice respond with primary lethality (zone D), survival with impaired regulatory and protective immunity (zone S), survival as protected but with impaired antibody conversion (zone P-) or complete recovery of normal responses (zone P+).
The 39 mice exposed to 460 R and the I6 mice exposed to 580 to 7oo R gave essentially synthesis. This compares with the total clearance of viraemia and rapid, early synthesis of antibody in control, unirradiated mice within 5 days of infection. The recovery of the normally rapid elimination of viraemia and development of antibody synthesis is not complete unless virus infection is delayed for about 60 days after whole-body exposure to 46o R.
DISCUSSION
It has been shown that the whole-body exposure of mice to sub-lethal doses (< 60o R) of y-radiation has little or no effect upon their susceptibility to infection or upon the initiation and early course of virus proliferation and immunogen production. Thus, the effects of y-irradiation upon the virus-host interaction are not upon the efficiency of primary infection or the pathogenic pathways but primarily upon the responses to immunogenic stimulation. The information presented suggests that all of the observed effects are related to y-radiation-induced delays in the stimulations which must be established if the course of host responses is to be regulated. This extends the concept that the irradiation of mice delays their production of humoral antibody (Murphy & Glasgow, ~968; Webb et al. T968; Spertzel et al. I975 ) to a wider range of host responses and to lower radiation doses.
The evidently minimal effects of y-irradiation upon receptor and phagocytic functions and the production of immunogens (Fig. ~ to 3) suggest that the delays in regulatory immunity are determined mainly by reductions in the number and competence of responsive lymphocytes. This is consistent with the greater sensitivity to y-irradiation shown when mice are infected with lower doses of virus (Fig. 4) and so offered lower or slower i~nmunogenic stimulation (Fitzgeorge & Bradish, t98o; Bradish etal. I98O) . Fig. 6 defines the recovery processes long after y-exposure and before virus infection and stimulation. In contrast, the several results on recovery processes following virus infection and immunogenic stimulation suggest that the decline of viraemia and rise in neutralizing activity of serum (antibody conversion)are major indicators of the recovery of normal B-lymphocyte functions in that individual. Tests in athymic-nude mice (Bradish et aI. t979, I98O ) have shown these early responses to SFV infection to be T-independent.
The regulation and elimination of infectivity in brain following y-irradiation, with the minimal incidence of primary deaths, probably indicates the recovery of normal levels of T-lymphocyte responses. This is consistent with other results on the regulation of brain infectivity in athymic-nude mice (Bradish et al. 1979 ) and the general y-resistance of cooperating macrophages (Gallily & Feldman, I967; gljivid, I97o; Anderson & Warner, I976 ). An identification of effects of this high y-dose range with the impairment of T-lymphocyte functions is similarly consistent with the saving by exposure to 50o R of mice infected with otherwise lethal strains of lymphocytic choriomeningitis (LCM) virus (Hotchin & Weigand, ~ 96I ; Bro-Jorgensen, ~978). These provisional identifications show the recoveries of the functions of T-and B-cells as the boundaries between the distinct phases of host responses to virus invasion and disease (Fig. 6) .
The development of protective immunity against later virulent challenge has shown an intermediate radiation sensitivity (,/-dose threshold) and recovery. This is consistent with a recovery of stimulated B-lymphocytes before the virulent challenge and with the further immunogenic stimulation of the challenge itself (Fig. 2) which allows protection to be established with or without primary antibody conversion (P+ and P-in Fig. 6 ). The re, coveries from radiation damage proceed at a rate of about 3 to 4 days per ~oo R of yexposure above the threshold dose of about 150 R. A similar estimate may be obtained from the study by Hotchin & Weigand (~96I) on the infection of mice by strains of LCM virus. The rate of functional recovery of virus-stimulated lymphocytes appears to be three to four times faster than that of I2 days per Ioo R shown in Fig. 6 for unstimulated cells. This rate of recovery of irnmunocompetence is close to that shown by the studies of Durum & Gengozian (1978) on the comparative radio-sensitivity and recovery of T-and B-lymphocytes. It is evident from any of these studies that the initial inactivation of ceils by y-radiation, the magnitude and competence of the surviving cell-fraction and the rate of recovery in number and competence, are separate aspects of radiation sensitivity which demand the most careful in vivo distinction.
In most in vivo studies of the present kind the estimates of immunocompetence or of its y-sensitivity are poorly reflected by conventional in vitro marker characteristics (Anderson & Warner, I976; Katz, I977; Durum and Gengozian, I978 ) . Furthermore, the bulk in vitro properties of lymphocyte classes may be difficult to relate to the residue of in vivo significant cells in critical tissues which survive y-irradiation and then respond to immune stimulation during the recovery process. These differential mechanisms are shown here through the y-radiation threshold doses for which sufficient cells survive to maintain regulation of that phase of host response to infecti6n. Information of this type provides a basis for the closer correlation of each phase of the virus-host interaction with the detail of its regulatory 
